This inventor holds 31 USPTO granted patents and 3 published patent applications and 3 EPO patents, primarily in Insecticidal Proteins. Top assignees: Monsanto Technology LLC, Immulogic Pharmaceutical Corporation, Merck Patent Gmbh. Active years: 1996-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (1996 - 2024)
- Cambridge, MA (US) (2020 - 2024)
Company Filing History:
14 out of 7,308 
6 out of 36 
3 out of 3,021 
Years Active: 1996-2026
Areas of Expertise:
Introduction
Jay Paul Morgenstern, based in Boston, MA, is a prolific inventor with a total of 27 patents to his name. His contributions to the field of biotechnology focus on innovative solutions for modulating biological processes and developing insecticidal proteins.
Latest Patents
Morgenstern's latest patents include significant advancements such as "Compounds that participate in cooperative binding and uses thereof." This invention features macrocyclic compounds that modulate biological processes by binding to presenter proteins like FKBP or cyclophilins, as well as target proteins such as CEP250. The compounds create binary complexes that selectively influence target protein activities, relying on essential protein-compound and protein-protein interactions for their modulation.
Additionally, he has developed "Pesticidal toxin proteins active against lepidopteran insects." This patent discloses nucleotide sequences encoding insecticidal proteins and includes novel variants designated as BCW 001, BCW 002, and BCW 003. The invention further details the use of transgenic plants that express these proteins and methods for detecting the insecticide in biological samples.
Career Highlights
Throughout his career, Morgenstern has worked with various prominent companies, including Monsanto Technology LLC and Immulogic Pharmaceutical Corporation. His work has not only contributed to scientific advancements but has also had a significant impact on agricultural biotechnology and pest control methodologies.
Collaborations
Morgenstern has collaborated with key figures in his field, including James Arthur Baum and Crystal L. Dart. These partnerships have likely fostered an environment of innovation and creativity, allowing for groundbreaking developments in biotechnology.
Conclusion
Jay Paul Morgenstern stands out as a leading inventor in the biotechnology sector. With a robust portfolio of patents and partnerships with notable companies and colleagues, his work continues to push the boundaries of scientific research, benefiting various industries through innovative solutions and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile